Monte Rosa Therapeutics Inc Cash Flow Quality Index
Monte Rosa Therapeutics Inc cash flow quality index. Monte Rosa Therapeutics Inc (GLUE) has a Cash Flow Quality Index of -0.97x as of March 2025. Operating cash flow of $-45.49 Million is below net income of $46.88 Million, suggesting accrual-heavy earnings not yet converted to cash. See GLUE financial flexibility score to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Monte Rosa Therapeutics Inc Cash Flow Quality Index by Year (None–None)
Monte Rosa Therapeutics Inc cash flow quality index by year from None to None. Year-by-year earnings quality comparison for Monte Rosa Therapeutics Inc. For the full cash flow conversion analysis, see Monte Rosa Therapeutics Inc operating cash flow efficiency.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|